These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38760888)

  • 21. In Vitro Inhibition of Renal OCT2 and MATE1 Secretion by Antiemetic Drugs.
    George B; Wen X; Jaimes EA; Joy MS; Aleksunes LM
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34208557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice.
    Li Q; Peng X; Yang H; Wang H; Shu Y
    Mol Pharm; 2011 Dec; 8(6):2476-83. PubMed ID: 21991918
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO).
    Gessner A; König J; Fromm MF
    Sci Rep; 2018 Apr; 8(1):6659. PubMed ID: 29704007
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and characterization of an endogenous biomarker of the renal vectorial transport (OCT2-MATE1).
    Ma Y; Wang X; Gou X; Wu X
    Biopharm Drug Dispos; 2024 Feb; 45(1):43-57. PubMed ID: 38305087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multidrug and toxic compound extrusion protein-1 (MATE1/SLC47A1) is a novel flavonoid transporter.
    Lee JH; Lee JE; Kim Y; Lee H; Jun HJ; Lee SJ
    J Agric Food Chem; 2014 Oct; 62(40):9690-8. PubMed ID: 25241911
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
    Wittwer MB; Zur AA; Khuri N; Kido Y; Kosaka A; Zhang X; Morrissey KM; Sali A; Huang Y; Giacomini KM
    J Med Chem; 2013 Feb; 56(3):781-795. PubMed ID: 23241029
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacogenomic Variants May Influence the Urinary Excretion of Novel Kidney Injury Biomarkers in Patients Receiving Cisplatin.
    Chang C; Hu Y; Hogan SL; Mercke N; Gomez M; O'Bryant C; Bowles DW; George B; Wen X; Aleksunes LM; Joy MS
    Int J Mol Sci; 2017 Jun; 18(7):. PubMed ID: 28640195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity.
    Guo D; Yang H; Li Q; Bae HJ; Obianom O; Zeng S; Su T; Polli JE; Shu Y
    Pharm Res; 2018 Sep; 35(11):204. PubMed ID: 30191328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Involvement of Renal Efflux Transporter MATE1 in Renal Excretion of Flecainide.
    Doki K; Apáti S; Sakata T; Homma M
    Biol Pharm Bull; 2019; 42(7):1226-1229. PubMed ID: 31257298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Double-transfected MDCK cells expressing human OCT1/MATE1 or OCT2/MATE1: determinants of uptake and transcellular translocation of organic cations.
    König J; Zolk O; Singer K; Hoffmann C; Fromm MF
    Br J Pharmacol; 2011 Jun; 163(3):546-55. PubMed ID: 20883471
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events.
    Iwata K; Aizawa K; Kamitsu S; Jingami S; Fukunaga E; Yoshida M; Yoshimura M; Hamada A; Saito H
    Clin Exp Nephrol; 2012 Dec; 16(6):843-51. PubMed ID: 22569819
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiloride is a suitable fluorescent substrate for the study of the drug transporter human multidrug and toxin extrusion 1 (MATE1).
    Kawasaki T; Kaneko C; Nakanishi R; Moriyama Y; Nabekura T
    Biochem Biophys Res Commun; 2022 Feb; 592():113-118. PubMed ID: 35042121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates.
    van der Velden M; Bilos A; van den Heuvel JJMW; Rijpma SR; Hurkmans EGE; Sauerwein RW; Russel FGM; Koenderink JB
    Malar J; 2017 Oct; 16(1):422. PubMed ID: 29061131
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal vectorial transport of berberine mediated by organic cation transporter 2 (OCT2) and multidrug and toxin extrusion proteins 1 (MATE1) in rats.
    Shi R; Yang Y; Xu Z; Dai Y; Zheng M; Wang T; Li Y; Ma Y
    Biopharm Drug Dispos; 2018 Jan; 39(1):47-58. PubMed ID: 29065218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The involvement of multidrug and toxin extrusion protein 1 in the distribution and excretion of berberine.
    Xiao L; Xue Y; Zhang C; Wang L; Lin Y; Pan G
    Xenobiotica; 2018 Mar; 48(3):314-323. PubMed ID: 28298174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2.
    Tanihara Y; Masuda S; Katsura T; Inui K
    Biochem Pharmacol; 2009 Nov; 78(9):1263-71. PubMed ID: 19540211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of vandetanib as an inhibitor of various human renal transporters: inhibition of multidrug and toxin extrusion as a possible mechanism leading to decreased cisplatin and creatinine clearance.
    Shen H; Yang Z; Zhao W; Zhang Y; Rodrigues AD
    Drug Metab Dispos; 2013 Dec; 41(12):2095-103. PubMed ID: 24026623
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multidrug and toxin extrusion family SLC47: physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K.
    Motohashi H; Inui K
    Mol Aspects Med; 2013; 34(2-3):661-8. PubMed ID: 23506899
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of non-linear Mate1-mediated efflux of trimethoprim in the mouse kidney as the mechanism underlying drug-drug interactions between trimethoprim and organic cations in the kidney.
    Kito T; Ito S; Mizuno T; Maeda K; Kusuhara H
    Drug Metab Pharmacokinet; 2019 Feb; 34(1):87-94. PubMed ID: 30528339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of tyrosine kinase inhibitors on renal handling of creatinine by MATE1.
    Omote S; Matsuoka N; Arakawa H; Nakanishi T; Tamai I
    Sci Rep; 2018 Jun; 8(1):9237. PubMed ID: 29915248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.